Structure of cortisone.
Find information on thousands of medical conditions and prescription drugs.

Cortisone

Cortisone is a hormone. Chemically it is a corticosteroid with formula C21H28O5 and IUPAC name 17-hydroxy-11-dehydrocorticosterone. It is closely related to corticosterone. more...

Home
Diseases
Medicines
A
B
C
Cabergoline
Caduet
Cafergot
Caffeine
Calan
Calciparine
Calcitonin
Calcitriol
Calcium folinate
Campath
Camptosar
Camptosar
Cancidas
Candesartan
Cannabinol
Capecitabine
Capoten
Captohexal
Captopril
Carbachol
Carbadox
Carbamazepine
Carbatrol
Carbenicillin
Carbidopa
Carbimazole
Carboplatin
Cardinorm
Cardiolite
Cardizem
Cardura
Carfentanil
Carisoprodol
Carnitine
Carvedilol
Casodex
Cataflam
Catapres
Cathine
Cathinone
Caverject
Ceclor
Cefacetrile
Cefaclor
Cefaclor
Cefadroxil
Cefazolin
Cefepime
Cefixime
Cefotan
Cefotaxime
Cefotetan
Cefpodoxime
Cefprozil
Ceftazidime
Ceftriaxone
Ceftriaxone
Cefuroxime
Cefuroxime
Cefzil
Celebrex
Celexa
Cellcept
Cephalexin
Cerebyx
Cerivastatin
Cerumenex
Cetirizine
Cetrimide
Chenodeoxycholic acid
Chloralose
Chlorambucil
Chloramphenicol
Chlordiazepoxide
Chlorhexidine
Chloropyramine
Chloroquine
Chloroxylenol
Chlorphenamine
Chlorpromazine
Chlorpropamide
Chlorprothixene
Chlortalidone
Chlortetracycline
Cholac
Cholybar
Choriogonadotropin alfa
Chorionic gonadotropin
Chymotrypsin
Cialis
Ciclopirox
Cicloral
Ciclosporin
Cidofovir
Ciglitazone
Cilastatin
Cilostazol
Cimehexal
Cimetidine
Cinchophen
Cinnarizine
Cipro
Ciprofloxacin
Cisapride
Cisplatin
Citalopram
Citicoline
Cladribine
Clamoxyquine
Clarinex
Clarithromycin
Claritin
Clavulanic acid
Clemastine
Clenbuterol
Climara
Clindamycin
Clioquinol
Clobazam
Clobetasol
Clofazimine
Clomhexal
Clomid
Clomifene
Clomipramine
Clonazepam
Clonidine
Clopidogrel
Clotrimazole
Cloxacillin
Clozapine
Clozaril
Cocarboxylase
Cogentin
Colistin
Colyte
Combivent
Commit
Compazine
Concerta
Copaxone
Cordarone
Coreg
Corgard
Corticotropin
Cortisone
Cotinine
Cotrim
Coumadin
Cozaar
Crestor
Crospovidone
Cuprimine
Cyanocobalamin
Cyclessa
Cyclizine
Cyclobenzaprine
Cyclopentolate
Cyclophosphamide
Cyclopropane
Cylert
Cyproterone
Cystagon
Cysteine
Cytarabine
Cytotec
Cytovene
Isotretinoin
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Cortisone and adrenaline are the main hormones released by the body as a reaction to stress. They elevate blood pressure and prepare the body for a fight or flight response.

Cortisone is the inactive precursor molecule of the active hormone Cortisol. It is activated through Hydroxylation of the 11-keto-group by an enzyme called 11-beta-Steroiddehydrogenase. The active form Cortisol is thus sometimes referred to as Hydrocortisone.

Cortisone is sometimes used as a drug to treat a variety of ailments. It can be administered intravenously or cutaneously.

One of cortisone's effects on the body, and a potentially harmful side effect when administered clinically is the suppression of the immune system. This is an explanation for the apparent correlation between high stress and sickness.

Cortisone was first discovered by the American chemist Edward Calvin Kendall. He won a Nobel Prize for Physiology or Medicine along with Philip S. Hench and Tadeus Reichstein for the discovery of the hormones of the adrenal cortex, their structure and function.

Read more at Wikipedia.org


[List your site here Free!]


The discovery of cortisone: a personal memory - Personal View
From British Medical Journal, 9/19/98 by John H. Glyn

Fifty years ago this week, Philip Hench showed that "compound E" (cortisone) was capable of reversing the inflammation of rheumatoid arthritis. This discovery resulted from 19 years of imaginative and deductive observation together, perhaps, with that element of serendipity which seems to characterise many fundamental discoveries.

It all started in 1929 when Hench noted a clinical remission in one of his patients who suffered an intercurrent episode of jaundice. Convinced that this was no coincidence he decided to devote himself to the discovery of the nature of "antirheumatic substance X" in remissions associated with jaundice, and later, with pregnancy. His clinical researches involved giving many metabolites related to liver disease and subsequently, female hormones related to pregnancy. They were uniformly unsuccessful.

Because remissions associated with jaundice occurred as frequently in women as in men, Hench concluded that factor X, if a hormone, must be present in both sexes. This led him to consider the adrenal cortex. He also noted that the gross fatigue seen in patients with rheumatoid arthritis bore some resemblance to the allergy which characterises Addison's disease.

By happy chance, his colleague and friend at the Mayo Clinic, Edward Kendall, had, in 1929, switched his research studies to the separation and characterisation of the many unidentified hormones of the adrenal cortex. This work was laborious and the yields extremely small. Nevertheless, Hench persuaded Kendall to allow him to use any extracts he could spare for therapeutic trials. Compounds labelled "A/D" proved ineffective, but compound "E," first administered on 21 September 1948, produced dramatic results.

Thus we learnt of long term bedridden disabled people attempting to dance. One patient insisted on taking several baths on the same day to compensate for the years during which such a luxury had been denied her.

Hench tried hard to restrict premature publicity outside the confines of the Mayo clinic until the full implications and complications of his discovery had been studied. However, a medical correspondent from the New York Times gained entry to a private meeting of Mayo Clinic alumni and published sensational stories and pictures in the lay press. This forced Hench's hand and he eventually announced his discovery to the Seventh International Congress of Rheumatology in May 1949.

Hench was a renowned Anglophile, and following the congress he invited several of his close British friends to visit the Mayo Clinic so that they could observe the therapeutic potency of cortisone for themselves. They were impressed, and on returning to Britain organised a motley team of clinicians and biochemists who decided to investigate the clinical significance of cortisone in rheumatoid arthritis. I was fortunate to be appointed as their research registrar. On Hench's introduction, they had obtained a promise from Merck Sharpe & Dohme that they would receive the first batch of cortisone which became available for export. There followed a tantalising delay of more than a year, during which time the production of cortisone in commercial quantities defeated biochemist and pharmaceutical companies alike. During this period all that we could do was to perfect our methods of clinical evaluation, while confirming that steroid analogues which did not contain the 17-hydroxy and 11-keto radicals were ineffective. It was precisely these radicals which proved so difficult to synthesise. In those days the only known starting point of semisynthes!s was from the bile of sheep and cattle. This seemed likely to limit supplies permanently.

In the United States a black market developed which had serious medical and social repercussions. Patients who had experienced great relief of their symptoms were not prepared to relapse when supplies ran out. They became totally dependent on the drug. Overdosage led to devastating side effects, and the ever escalating cost of maintaining their supplies resulted all too often in financial destitution. Such patients had no alternative but to seek relief by registering as guinea pigs to research groups such as the one at the Bellevue Hospital in New York which I joined in 1952.

Eventually, in 1954, under the joint aegis of the Nuffield Foundation and the Medical Research Council, a British trial was organised in six centres in which the benefits of cortisone were studied in 61 patients with rheumatoid arthritis in a crossover trial against aspirin. The published results startlingly concluded that there was no significant difference between the two groups (BMJ 1954;i:1223-7).

Philip Hench was deeply offended by these conclusions especially as they were signed by many colleagues whom he had numbered among his greatest friends. Indeed he was heard to refer to some of the signatories as traitors and he refused any further association with them.

I felt that the crossover nature of the trial and some of the methods of evaluation gave rise to an unrealistic conclusion and I imprudently wrote a letter (BMJ 1954;i: 1376). My letter drew an angry reply from Sir Austin Bradford-Hill, the distinguished medical statistician who had designed the trial protocol (BMJ 1954;i:1437). I met him many years later and he graciously agreed that some of my comments were justified in the light of subsequent events.

A few weeks later, there was a totally unexpected repercussion in the form of a letter to me from Philip Hench, asking me whether I thought that the atmosphere in Britain was propitious for him to accept an invitation to come and address a BMA meeting. He was not prepared to come if there was any risk of being heckled.

From this improbable beginning, a close friendship developed between this great man and my family. In fact he was in our house the day before the birth of my daughter and, at his insistence, she bears the female version of his first name. It was only with some difficulty that we resisted the idea that she should be christened Cortisona.

Philip Hench had a charismatic and generous personality. He was a man of diverse and enthusiastic interests outside medicine. His sensitivity on the subject of his seminal contribution to medicine was unfortunate, and it undoubtedly marred the pleasure he should have derived from his fame and from the Nobel prize for medicine in 1950. It was especially unfortunate in view of his original intention to present his discovery as an investigative tool rather than as a therapeutic breakthrough.

The clinical usefulness of cortisone in rheumatology remains controversial 50 years after the event, but without doubt its discovery transformed the specialty from its Cinderella status of the BC (before cortisone) era. Its significance in general medicine remains beyond dispute.

COPYRIGHT 1998 British Medical Association
COPYRIGHT 2000 Gale Group

Return to Cortisone
Home Contact Resources Exchange Links ebay